ZymaDerm is ‘FDA Compliant’ and conforms to the standards of the Homeopathic Pharacopeia of the United States (HPUS), a compendium recognized as both official and authoritative by the FDA.
Each of the ingredients in ZymaDerm is stated in the Pharmacopeia to be useful as an aid in the treatment of skin rash conditions. If a drug-free agent is listed in the HPUS for treating certain conditions, a product containing that agent may be marketed for those conditions without specific FDA approval. The approval has already been granted for those agents listed, as long as the concentrations used in the product are within the specified limits. ZymaDerm meets these criteria as specified in the HPUS. For more information you may search FDA regulations in the Code of Federal Regulations (see “Safety” for link to the FDA web site). Please note ZymaDerm is a TOPICAL, not an ORAL homeopathic. As such, it is not infinitely dilute as with traditional oral homeopathics.
Zymaderm is not available in India.